Navigation Links
Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
Date:9/17/2008

Curemark, LLC announced today that Founder and CEO Dr. Joan Fallon has presented Curemark's most recent findings on autism at the Gordon Conference on Neurobiology and Brain Disorders which took place August 24-29 at Magdalene College in Oxford.

Rye, NY (PRWEB) September 17, 2008 -- www.cure-mark.com [Curemark, LLC] announced today that Founder and CEO Dr. Joan Fallon has presented Curemark's most recent findings on autism at the Gordon Conference on Neurobiology and Brain Disorders which took place August 24-29 at Magdalene College in Oxford. This 5-day conference brings together some of the greatest research minds from around the world in the field of neurobiology both from academia and industry.

Dr. Fallon's paper, entitled, "The Role of a Dearth of Amino Acids in the Pathophysiology of Autism" details the groundbreaking discoveries regarding autism and its possible origins. This research is the focus of Curemark's plans for entering into clinical trials.

"It was an incredible honor to be among the most elite scientists in the world looking at the genetics of autism, Alzheimer's, Parkinson's disease and other neurodegenerative conditions." Commented Dr.Fallon, The Gordon Conferences are one of pre-eminent meetings in the world, and I am grateful that Curemark was able to be represented."

Present at the meeting were scientists from MIT, Harvard, Johns Hopkins, Oxford, Cambridge and other prestigious universities from around the world.

Curemark is a drug development company focused on the treatment of neurological and other diseases by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of key enzymes in children with autism. The company is currently preparing for Clinical Trials. To learn more about Curemark's innovative science, visit www.cure-mark.com.

For more information, contact:
Alissa Minio
info @ cure-mark.com
(914) 925-3450

# # #

Read the full story at http://www.prweb.com/releases/Curemark/Neurobiology_Conference/prweb1338504.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. AMA Foundation Presents the Arthur N. Wilson, MD Scholarship to Promising Medical Student From Southeast Alaska
2. USA-ONE Interactive Presents a Free Webinar Series Introducing Docuvation – An Online Document Management Solution
3. AMA Foundation Presents $10,000 Scholarships to Promising Medical Students
4. Neurotherapeutics presents special issue on new treatments for Alzheimers disease
5. Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
6. Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
7. ExonHit Presents Therapeutic and Diagnostic Programs for Alzheimers at ICAD 2008
8. OptiNose presents data on highly effective migraine treatment
9. International Association for Dental Research presents awards and fellowships
10. MIKE AND IKE(R) Lemonade Blends(TM) Presents $100,000 to Alexs Lemonade Stand Foundation
11. Journal STEM CELLS Presents 3rd Annual Young Investigator Award at International Stem Cell Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... ANN ARBOR, Mich. (PRWEB) , ... ... ... Global Retailer and Manufacturer Alliance (GRMA) is growing as it continues developing ... the dietary supplement industry. The organization, which plans to publish the first ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... oral braces. "The rubber bands used in conjunction with my braces always rubbed ... to design a way to prevent this problem." The O.B.S. was the result ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly ... assembly protocols involve many repetitive steps and often scientists require many different versions ... high-throughput needed, and results in a lower error rate and cost saving for ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology: